Health
Nasal spray to fight COVID-19 could be manufactured in Australia – Manufacturers’ Monthly
A nasal treatment for COVID-19, common colds and flu is being taken to the next stage of testing, backed by the $500 million Biomedical Translation Fund.
A nasal treatment for COVID-19, common colds and flu is being taken to the next stage of testing, with backing from the federal government’s $500 million Biomedical Translation Fund.
Developed by Australian biotech company Ena Respiratory, INNA-051 works by stimulating the innate immune system, the first line of defence against the invasion of pathogens into the body.
The government, with Brandon Capital Partners has committed $11.7 million to test the nasal spray treatment, that targets the primary…
-
Noosa News23 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News12 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News22 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
Noosa News21 hours agoMissing man, Maroochydore – Queensland Police News